Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mesenchymal Stem Cell: A New Horizon in Cancer Gene Therapy Publisher Pubmed



Mohammadi M1 ; Jaafari MR2 ; Mirzaei HR3 ; Mirzaei H4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hepatitis Research Center, Department of Pharmaceutical Biotechnology, Lorestan University of Medical Sciences, Khorramabad, Iran
  2. 2. Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, 1417613151, Iran
  4. 4. Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, 91779-48564, Iran

Source: Cancer Gene Therapy Published:2016


Abstract

Cancer is one of the main problems in public health worldwide. Despite rapid advances in the diagnosis and treatment of cancer, the efficacy of current treatment strategies is still limited. There are promising new results in animal models whereby mesenchymal stem cells (MSCs) can be used as vehicles for targeted therapies. The use of MSCs as therapeutic biological vehicles in cell therapy has several advantages, including immune-silence, tumor tropism, easy and rapid isolation, ex vivo expansion, multilineage differentiation and the capacity to deliver a number of therapeutic agents. Some studies have shown that the microenvironment of the tumor provides a preferential niche for homing and survival of MSCs. Here, we have highlighted various applications of MSCs in cancer gene therapy. © 2016 Nature America, Inc., part of Springer Nature.